ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the fiscal year ended | ||||||||
OR | ||||||||
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the transition period | from ________ to ________ | |||||||
| (State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | ||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| ☒ | Accelerated filer | ☐ | |||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
| Emerging growth company | |||||||||||
| Class | Outstanding at February 12, 2025 | ||||||||||
| Common Stock, $0.01 par value per share | shares | ||||||||||
Documents Incorporated by Reference: Certain portions of the Definitive Proxy Statement for the 2025 Annual Meeting of Shareholders are incorporated by reference into Part III of this Form 10-K. | |||||
Page | ||||||||
| Item 1. | ||||||||
| Item 1A. | ||||||||
| Item 1B. | ||||||||
Item 1C. | ||||||||
| Item 2. | ||||||||
| Item 3. | ||||||||
| Item 4. | ||||||||
| Item 5. | ||||||||
| Item 6. | ||||||||
| Item 7. | ||||||||
| Item 7A. | ||||||||
| Item 8. | ||||||||
| Item 9. | ||||||||
| Item 9A. | ||||||||
| Item 9B. | ||||||||
| Item 9C. | ||||||||
| Item 10. | ||||||||
| Item 11. | ||||||||
| Item 12. | ||||||||
| Item 13. | ||||||||
| Item 14. | ||||||||
| Item 15. | ||||||||
| Item 16. | ||||||||
Operating company IPOs | 130 | ||||
SPAC IPOs | 50 | ||||
| Switches from the New York Stock Exchange LLC, or NYSE, and the NYSE American LLC, or NYSE American | 17 | ||||
| Upgrades from OTC | 22 | ||||
| ETPs and Other Listings | 244 | ||||
Total | 463 | ||||
The Nasdaq Stock Market eligible IPO win rates: | |||||
2024 total | 82 | % | |||
| Operating companies | 80 | % | |||



| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions) | ||||||||||||||||||||||
October 2024 | ||||||||||||||||||||||||||
| Share repurchase program | — | $ | — | — | $ | 1,745 | ||||||||||||||||||||
| Employee transactions | 4,444 | $ | 73.00 | N/A | N/A | |||||||||||||||||||||
November 2024 | ||||||||||||||||||||||||||
| Share repurchase program | — | $ | — | — | $ | 1,745 | ||||||||||||||||||||
| Employee transactions | 10,561 | $ | 74.32 | N/A | N/A | |||||||||||||||||||||
December 2024 | ||||||||||||||||||||||||||
| Share repurchase program | — | $ | — | — | $ | 1,745 | ||||||||||||||||||||
| Employee transactions | 44,463 | $ | 79.38 | N/A | N/A | |||||||||||||||||||||
Total Quarter Ended December 31, 2024 | ||||||||||||||||||||||||||
| Share repurchase program | — | $ | — | — | $ | 1,745 | ||||||||||||||||||||
| Employee transactions | 59,468 | $ | 78.00 | N/A | N/A | |||||||||||||||||||||
Year Ended December 31, | |||||||||||||||||||||||||||||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||||||||||||||||||||||
| Nasdaq, Inc. | $ | 100 | $ | 126 | $ | 202 | $ | 179 | $ | 173 | $ | 233 | |||||||||||||||||||||||
| Nasdaq Composite Index | 100 | 145 | 177 | 119 | 173 | 224 | |||||||||||||||||||||||||||||
| S&P 500 | 100 | 118 | 152 | 125 | 158 | 197 | |||||||||||||||||||||||||||||
S&P 500 GICS 4020 Index | 100 | 111 | 151 | 134 | 155 | 199 | |||||||||||||||||||||||||||||

Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions, except per share amounts) | ||||||||||||||||||||||||||
| Revenues less transaction-based expenses | $ | 4,649 | $ | 3,895 | $ | 3,582 | 19.4 | % | 8.8 | % | ||||||||||||||||
| Operating expenses | 2,851 | 2,317 | 2,018 | 23.0 | % | 14.9 | % | |||||||||||||||||||
| Operating income | $ | 1,798 | $ | 1,578 | $ | 1,564 | 13.9 | % | 0.8 | % | ||||||||||||||||
| Net income attributable to Nasdaq | $ | 1,117 | $ | 1,059 | $ | 1,125 | 5.5 | % | (5.9) | % | ||||||||||||||||
| Diluted earnings per share | $ | 1.93 | $ | 2.08 | $ | 2.26 | (7.4) | % | (7.8) | % | ||||||||||||||||
| Cash dividends declared per common share | $ | 0.94 | $ | 0.86 | $ | 0.78 | 9.3 | % | 10.3 | % | ||||||||||||||||

▪ | Capital Access Platforms | |||||||
◦ | Proprietary market data subscriptions and annual listing fees within our Data & Listing Services business | |||||||
◦ | Index data subscriptions and guaranteed minimum on futures contracts within our Index business | |||||||
◦ | Subscription contracts under our Workflow & Insights business | |||||||
▪ | Financial Technology | |||||||
◦ | Financial Crime Management Technology SaaS subscription contracts excluding one-time service requests | |||||||
◦ | Regulatory Technology SaaS subscription and support contracts excluding one-time service requests | |||||||
◦ | Capital Markets Technology SaaS subscription and support contracts excluding one-time service requests | |||||||

| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| Capital Access Platforms | $ | 1,972 | $ | 1,770 | $ | 1,682 | 11.4 | % | 5.2 | % | ||||||||||||||||
| Financial Technology | 1,621 | 1,099 | 864 | 47.5 | % | 27.1 | % | |||||||||||||||||||
| Market Services | 3,771 | 3,156 | 3,632 | 20.9 | % | (13.4) | % | |||||||||||||||||||
| Other revenues | 36 | 39 | 48 | (8.6) | % | (16.9) | % | |||||||||||||||||||
| Total revenues | $ | 7,400 | $ | 6,064 | $ | 6,226 | 22.0 | % | (2.6) | % | ||||||||||||||||
| Transaction rebates | (2,026) | (1,838) | (2,092) | 10.2 | % | (12.1) | % | |||||||||||||||||||
| Brokerage, clearance and exchange fees | (725) | (331) | (552) | 119.1 | % | (40.1) | % | |||||||||||||||||||
| Total revenues less transaction-based expenses | $ | 4,649 | $ | 3,895 | $ | 3,582 | 19.4 | % | 8.8 | % | ||||||||||||||||

| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| Data & Listing Services | $ | 754 | $ | 749 | $ | 727 | 0.7 | % | 3.0 | % | ||||||||||||||||
| Index | 706 | 528 | 486 | 33.7 | % | 8.6 | % | |||||||||||||||||||
| Workflow & Insights | 512 | 493 | 469 | 3.8 | % | 5.2 | % | |||||||||||||||||||
| Total Capital Access Platforms | $ | 1,972 | $ | 1,770 | $ | 1,682 | 11.4 | % | 5.2 | % | ||||||||||||||||
As of December 31, | ||||||||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||||||||
| ARR (in millions) | $ | 1,268 | $ | 1,235 | $ | 1,190 | ||||||||||||||
| Year Ended December 31, | ||||||||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||||||||
| IPOs | ||||||||||||||||||||
| The Nasdaq Stock Market | 180 | 130 | 161 | |||||||||||||||||
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 14 | 7 | 38 | |||||||||||||||||
| Total new listings | ||||||||||||||||||||
| The Nasdaq Stock Market | 463 | 330 | 366 | |||||||||||||||||
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 31 | 23 | 63 | |||||||||||||||||
As of December 31, | ||||||||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||||||||
| Number of listed companies | ||||||||||||||||||||
| The Nasdaq Stock Market | 4,075 | 4,044 | 4,230 | |||||||||||||||||
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 1,174 | 1,218 | 1,251 | |||||||||||||||||
| ARR (in millions) | 691 | 682 | 664 | |||||||||||||||||
As of or Year Ended December 31, | ||||||||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||||||||
| Number of licensed ETPs | 401 | 364 | 348 | |||||||||||||||||
| TTM change in period end ETP AUM tracking Nasdaq indices (in billions) | ||||||||||||||||||||
| Beginning balance | $ | 473 | $ | 315 | $ | 424 | ||||||||||||||
Net appreciation (depreciation) | 110 | 128 | (142) | |||||||||||||||||
| Net impact of ETP sponsor switches | (16) | (1) | (1) | |||||||||||||||||
| Net inflows | 80 | 31 | 34 | |||||||||||||||||
| Ending balance | $ | 647 | $ | 473 | $ | 315 | ||||||||||||||
Annual average ETP AUM tracking Nasdaq indices (in billions) | $ | 558 | $ | 396 | $ | 351 | ||||||||||||||
| ARR (in millions) | $ | 76 | $ | 72 | $ | 68 | ||||||||||||||
As of or Year Ended December 31 | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| ARR | $ | 501 | $ | 481 | $ | 458 | |||||||||||
| Quarterly annualized SaaS revenues | 431 | 411 | 388 | ||||||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
Financial Crime Management Technology | $ | 273 | $ | 223 | $ | 176 | 22.2 | % | 26.5 | % | ||||||||||||||||
Regulatory Technology | 352 | 212 | 130 | 66.3 | % | 63.5 | % | |||||||||||||||||||
Capital Markets Technology | 996 | 664 | 558 | 50.0 | % | 18.9 | % | |||||||||||||||||||
| Total Financial Technology | $ | 1,621 | $ | 1,099 | $ | 864 | 47.5 | % | 27.1 | % | ||||||||||||||||
As of or Year Ended December 31 | ||||||||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||||||||
| (in millions) | ||||||||||||||||||||
| ARR and Quarterly annualized SaaS revenues | $ | 278 | $ | 226 | $ | 182 | ||||||||||||||
As of or Year Ended December 31 | ||||||||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||||||||
| (in millions) | ||||||||||||||||||||
| ARR | $ | 354 | $ | 325 | $ | 130 | ||||||||||||||
| Quarterly annualized SaaS revenues | 191 | 165 | 116 | |||||||||||||||||
As of or Year Ended December 31 | ||||||||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||||||||
| (in millions) | ||||||||||||||||||||
| ARR | $ | 868 | $ | 799 | $ | 499 | ||||||||||||||
| Quarterly annualized SaaS revenues | 134 | 108 | 39 | |||||||||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| Market Services | $ | 3,771 | $ | 3,156 | $ | 3,632 | 20.9 | % | (13.4) | % | ||||||||||||||||
| Transaction-based expenses: | ||||||||||||||||||||||||||
| Transaction rebates | (2,026) | (1,838) | (2,092) | 10.2 | % | (12.1) | % | |||||||||||||||||||
Brokerage, clearance and exchange fees | (725) | (331) | (552) | 119.1 | % | (40.1) | % | |||||||||||||||||||
| Total Market Services, net | $ | 1,020 | $ | 987 | $ | 988 | 3.4 | % | (0.1) | % | ||||||||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| U.S. Equity Derivative Trading | $ | 395 | $ | 374 | $ | 371 | 5.7 | % | 0.7 | % | ||||||||||||||||
| Cash Equity Trading | 430 | 397 | 397 | 8.3 | % | — | % | |||||||||||||||||||
| U.S. Tape plans | 125 | 141 | 149 | (11.5) | % | (5.4) | % | |||||||||||||||||||
| Other | 70 | 75 | 71 | (6.2) | % | 4.6 | % | |||||||||||||||||||
| Total Market Services, net | $ | 1,020 | $ | 987 | $ | 988 | 3.4 | % | (0.1) | % | ||||||||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| U.S. Equity Derivative Trading Revenues | $ | 1,428 | $ | 1,257 | $ | 1,252 | 13.6 | % | 0.4 | % | ||||||||||||||||
Section 31 fees | 87 | 55 | 89 | 56.9 | % | (37.9) | % | |||||||||||||||||||
| Transaction-based expenses: | ||||||||||||||||||||||||||
| Transaction rebates | (1,030) | (879) | (878) | 17.1 | % | 0.2 | % | |||||||||||||||||||
Section 31 fees | (87) | (55) | (89) | 56.9 | % | (37.9) | % | |||||||||||||||||||
| Brokerage and clearance fees | (3) | (4) | (3) | (16.5) | % | 13.9 | % | |||||||||||||||||||
U.S. Equity Derivative Trading Revenues, net | $ | 395 | $ | 374 | $ | 371 | 5.7 | % | 0.7 | % | ||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| U.S. equity options | |||||||||||||||||
| Total industry average daily volume (in millions) | 44.4 | 40.4 | 38.2 | ||||||||||||||
| Nasdaq PHLX matched market share | 10.0 | % | 11.3 | % | 11.6 | % | |||||||||||
| The Nasdaq Options Market matched market share | 5.5 | % | 6.1 | % | 8.0 | % | |||||||||||
| Nasdaq BX Options matched market share | 2.1 | % | 3.3 | % | 2.8 | % | |||||||||||
| Nasdaq ISE Options matched market share | 6.9 | % | 5.9 | % | 5.7 | % | |||||||||||
| Nasdaq GEMX Options matched market share | 2.6 | % | 2.4 | % | 2.3 | % | |||||||||||
| Nasdaq MRX Options matched market share | 2.7 | % | 2.0 | % | 1.6 | % | |||||||||||
| Total matched market share executed on Nasdaq’s exchanges | 29.8 | % | 31.0 | % | 32.0 | % | |||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| Cash Equity Trading Revenues | $ | 1,428 | $ | 1,355 | $ | 1,605 | 5.4 | % | (15.6) | % | ||||||||||||||||
Section 31 fees | 611 | 253 | 436 | 141.7 | % | (42.0) | % | |||||||||||||||||||
| Transaction-based expenses: | ||||||||||||||||||||||||||
| Transaction rebates | (974) | (939) | (1,184) | 3.8 | % | (20.8) | % | |||||||||||||||||||
Section 31 fees | (611) | (253) | (436) | 141.7 | % | (41.9) | % | |||||||||||||||||||
| Brokerage and clearance fees | (24) | (19) | (24) | 29.5 | % | (22.3) | % | |||||||||||||||||||
| Cash equity trading revenues, net | $ | 430 | $ | 397 | $ | 397 | 8.3 | % | — | % | ||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Total U.S.-listed securities | |||||||||||||||||
| Total industry average daily share volume (in billions) | 12.2 | 11.0 | 11.9 | ||||||||||||||
| Matched share volume (in billions) | 479.4 | 455.6 | 522.8 | ||||||||||||||
| The Nasdaq Stock Market matched market share | 15.1 | % | 15.8 | % | 16.2 | % | |||||||||||
| Nasdaq BX matched market share | 0.3 | % | 0.4 | % | 0.5 | % | |||||||||||
| Nasdaq PSX matched market share | 0.2 | % | 0.3 | % | 0.8 | % | |||||||||||
| Total matched market share executed on Nasdaq’s exchanges | 15.6 | % | 16.5 | % | 17.5 | % | |||||||||||
| Market share reported to the FINRA/Nasdaq Trade Reporting Facility | 44.3 | % | 36.7 | % | 35.2 | % | |||||||||||
| Total market share | 59.9 | % | 53.2 | % | 52.7 | % | |||||||||||
| Nasdaq Nordic and Nasdaq Baltic securities | |||||||||||||||||
| Average daily number of equity trades executed on Nasdaq’s exchanges | 651,455 | 666,411 | 908,813 | ||||||||||||||
| Total average daily value of shares traded (in billions) | $ | 4.5 | $ | 4.5 | $ | 5.4 | |||||||||||
| Total market share executed on Nasdaq’s exchanges | 71.9 | % | 71.0 | % | 71.5 | % | |||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| U.S. Tape plans | $ | 125 | $ | 141 | $ | 149 | (11.5) | % | (5.4) | % | ||||||||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| Other | $ | 70 | $ | 75 | $ | 71 | (6.2) | % | 4.6 | % | ||||||||||||||||
| Year Ended December 31, | Percentage Change | ||||||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | |||||||||||||||||||||||||
| (in millions) | |||||||||||||||||||||||||||||
| Compensation and benefits | $ | 1,324 | $ | 1,082 | $ | 1,003 | 22.4% | 7.9% | |||||||||||||||||||||
| Professional and contract services | 152 | 128 | 140 | 18.4% | (8.6)% | ||||||||||||||||||||||||
| Technology and communication infrastructure | 281 | 233 | 207 | 20.9% | 12.7% | ||||||||||||||||||||||||
| Occupancy | 112 | 129 | 104 | (12.9)% | 23.7% | ||||||||||||||||||||||||
| General, administrative and other | 109 | 113 | 125 | (3.6)% | (9.8)% | ||||||||||||||||||||||||
| Marketing and advertising | 54 | 47 | 51 | 16.4% | (8.8)% | ||||||||||||||||||||||||
| Depreciation and amortization | 613 | 323 | 258 | 89.3% | 25.5% | ||||||||||||||||||||||||
| Regulatory | 55 | 34 | 33 | 60.8% | 4.4% | ||||||||||||||||||||||||
| Merger and strategic initiatives | 35 | 148 | 82 | (76.5)% | 79.7% | ||||||||||||||||||||||||
| Restructuring charges | 116 | 80 | 15 | 44.3% | 454.5% | ||||||||||||||||||||||||
| Total operating expenses | $ | 2,851 | $ | 2,317 | $ | 2,018 | 23.0% | 14.9% | |||||||||||||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| Interest income | $ | 28 | $ | 115 | $ | 7 | (75.5) | % | 1,538.3 | % | ||||||||||||||||
| Interest expense | (414) | (284) | (129) | 45.6 | % | 120.2 | % | |||||||||||||||||||
| Net interest expense | (386) | (169) | (122) | 128.3 | % | 38.4 | % | |||||||||||||||||||
| Other income (loss) | 21 | (1) | 2 | (5,232.5) | % | (121.9) | % | |||||||||||||||||||
| Net income (loss) from unconsolidated investees | 16 | (7) | 31 | (328.7) | % | (122.9) | % | |||||||||||||||||||
| Total non-operating expense | $ | (349) | $ | (177) | $ | (89) | 97.4 | % | 96.7 | % | ||||||||||||||||
| Year Ended December 31, | Percentage Change | ||||||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | |||||||||||||||||||||||||
| (in millions) | |||||||||||||||||||||||||||||
| Interest expense on debt | $ | 398 | $ | 272 | $ | 120 | 46.3 | % | 126.8 | % | |||||||||||||||||||
| Accretion of debt issuance costs and debt discount | 13 | 9 | 7 | 33.9 | % | 37.0 | % | ||||||||||||||||||||||
| Other fees | 3 | 3 | 2 | 18.7 | % | 21.2 | % | ||||||||||||||||||||||
| Interest expense | $ | 414 | $ | 284 | $ | 129 | 45.6 | % | 120.2 | % | |||||||||||||||||||
| Year Ended December 31, | Percentage Change | |||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| Income tax provision | $ | 334 | $ | 344 | $ | 352 | (2.8) | % | (2.1) | % | ||||||||||||||||
| Effective tax rate | 23.1 | % | 24.6 | % | 23.9 | % | ||||||||||||||||||||
Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions, except per share amounts) | |||||||||||||||||
| U.S. GAAP net income attributable to Nasdaq | $ | 1,117 | $ | 1,059 | $ | 1,125 | |||||||||||
| Non-GAAP adjustments: | |||||||||||||||||
| Adenza purchase accounting adjustment | 34 | — | — | ||||||||||||||
| Amortization expense of acquired intangible assets | 488 | 206 | 153 | ||||||||||||||
| Merger and strategic initiatives expense | 35 | 148 | 82 | ||||||||||||||
| Restructuring charges | 116 | 80 | 15 | ||||||||||||||
| Lease asset impairments | — | 25 | — | ||||||||||||||
| Extinguishment of debt | 4 | — | 16 | ||||||||||||||
| Net (income) loss from unconsolidated investees | (16) | 7 | (29) | ||||||||||||||
| Legal and regulatory matters | 20 | 12 | 26 | ||||||||||||||
Pension settlement charge | 23 | 9 | — | ||||||||||||||
| Other (income) loss | (15) | 21 | 2 | ||||||||||||||
| Total non-GAAP adjustments | $ | 689 | $ | 508 | $ | 265 | |||||||||||
| Total non-GAAP tax adjustments | (208) | (134) | (66) | ||||||||||||||
| Tax on intra-group transfer of IP assets | 33 | — | — | ||||||||||||||
| Total non-GAAP adjustments, net of tax | $ | 514 | $ | 374 | $ | 199 | |||||||||||
| Non-GAAP net income attributable to Nasdaq | $ | 1,631 | $ | 1,433 | $ | 1,324 | |||||||||||
| U.S. GAAP effective tax rate | 23.1 | % | 24.6 | % | 23.9 | % | |||||||||||
| Total adjustments from non-GAAP tax rate | 0.7 | % | 0.4 | % | 0.1 | % | |||||||||||
| Non-GAAP effective tax rate | 23.8 | % | 25.0 | % | 24.0 | % | |||||||||||
| Weighted-average common shares outstanding for diluted earnings per share | 579.2 | 508.4 | 497.9 | ||||||||||||||
| U.S. GAAP diluted earnings per share | $ | 1.93 | $ | 2.08 | $ | 2.26 | |||||||||||
| Total adjustments from non-GAAP net income | 0.89 | 0.74 | 0.40 | ||||||||||||||
| Non-GAAP diluted earnings per share | $ | 2.82 | $ | 2.82 | $ | 2.66 | |||||||||||
| December 31, 2024 | December 31, 2023 | |||||||||||||
| (in millions) | ||||||||||||||
| Cash and cash equivalents | $ | 592 | $ | 453 | ||||||||||
| Financial investments | 184 | 188 | ||||||||||||
| Working capital | (116) | 71 | ||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Net cash provided by (used in): | (in millions) | ||||||||||||||||
| Operating activities | $ | 1,939 | $ | 1,696 | $ | 1,706 | |||||||||||
| Investing activities | (953) | (5,994) | 49 | ||||||||||||||
| Financing activities | (2,561) | 4,220 | 1,036 | ||||||||||||||
| 2024 | 2023 | ||||||||||
| First quarter | $ | 0.22 | $ | 0.20 | |||||||
| Second quarter | 0.24 | 0.22 | |||||||||
| Third quarter | 0.24 | 0.22 | |||||||||
| Fourth quarter | 0.24 | 0.22 | |||||||||
| Total | $ | 0.94 | $ | 0.86 | |||||||

| Payments Due by Period | |||||||||||||||||
| (in millions) | Total | <1 year | 1-3 years | 3-5 years | 5+ years | ||||||||||||
| Debt obligation by contractual maturity | $ | 15,252 | $ | 761 | $ | 1,171 | $ | 2,148 | $ | 11,172 | |||||||
| Operating lease obligations | 617 | 75 | 140 | 129 | 273 | ||||||||||||
| Purchase obligations | 384 | 96 | 115 | 89 | 84 | ||||||||||||
| Total | $ | 16,253 | $ | 932 | $ | 1,426 | $ | 2,366 | $ | 11,529 | |||||||
| Euro | Swedish Krona | Canadian Dollar | Other Foreign Currencies | U.S. Dollar | |||||||||||||
| (in millions, except currency rate) | |||||||||||||||||
Year Ended December 31, 2024 | |||||||||||||||||
| Average foreign currency rate to the U.S. dollar | 1.082 | 0.095 | 0.730 | # | N/A | ||||||||||||
| Percentage of revenues less transaction-based expenses | 7.9% | 3.4% | 0.7% | 3.7% | 84.3% | ||||||||||||
| Percentage of operating income | 11.8% | (5.9)% | (7.8)% | (10.5)% | 112.4% | ||||||||||||
| Impact of a 10% adverse currency fluctuation on revenues less transaction-based expenses | $(37) | $(16) | $(3) | $(17) | $— | ||||||||||||
| Impact of a 10% adverse currency fluctuation on operating income | $(21) | $(11) | $(14) | $(19) | $— | ||||||||||||
| Euro | Swedish Krona | Canadian Dollar | Other Foreign Currencies | U.S. Dollar | |||||||||||||
| (in millions, except currency rate) | |||||||||||||||||
Year Ended December 31, 2023 | |||||||||||||||||
| Average foreign currency rate to the U.S. dollar | 1.081 | 0.094 | 0.741 | # | N/A | ||||||||||||
| Percentage of revenues less transaction-based expenses | 6.6% | 4.0% | 0.8% | 3.0% | 85.6% | ||||||||||||
| Percentage of operating income | 10.7% | (3.8)% | (7.0)% | (8.3)% | 108.4% | ||||||||||||
| Impact of a 10% adverse currency fluctuation on revenues less transaction-based expenses | $(26) | $(15) | $(3) | $(12) | $— | ||||||||||||
| Impact of a 10% adverse currency fluctuation on operating income | $(17) | $(6) | $(11) | $(13) | $— | ||||||||||||
| Net Assets | Impact of a 10% Adverse Currency Fluctuation | |||||||||||||
| (in millions) | ||||||||||||||
| Swedish Krona | $ | 2,737 | $ | (274) | ||||||||||
| British Pound | 136 | (14) | ||||||||||||
| Norwegian Krone | 134 | (13) | ||||||||||||
| Canadian Dollar | 107 | (11) | ||||||||||||
| Australian Dollar | 89 | (9) | ||||||||||||
| October 1, 2024 | |||||
| (in millions) | |||||
| Capital Access Platforms | $ | 4,210 | |||
Financial Technology | 7,945 | ||||
Market Services | 2,010 | ||||
| $ | 14,165 | ||||
| Plan Category | Number of shares to be issued upon exercise of outstanding options, warrants and rights(a) | Weighted-average exercise price of outstanding options, warrants and rights(b) | Number of shares remaining available for future issuance under equity compensation plans (excluding shares reflected in column(a))(c) | |||||||||||||||||
| Equity compensation plans approved by stockholders | 1,420,323 | $ | 41.79 | 33,615,389 | ||||||||||||||||
| Equity compensation plans not approved by stockholders | — | — | — | |||||||||||||||||
| Total | 1,420,323 | $ | 41.79 | 33,615,389 | ||||||||||||||||
| Exhibit Number | ||||||||
Share Purchase Agreement, dated as of November 18, 2020, by and among Osprey Acquisition Corporation, a wholly owned subsidiary of Nasdaq, Verafin Holdings Inc., certain shareholders of Verafin (the “Sellers”), and Shareholder Representative Services LLC, solely in its capacity as the representative of the Sellers (incorporated herein by reference to Exhibit 2.2 to the Annual Report on Form 10-K for the year ended December 31, 2020 filed on February 23, 2021).† | ||||||||
Amendment to Share Purchase Agreement, dated as of February 11, 2021, by and among Osprey Acquisition Corporation, a wholly owned subsidiary of Nasdaq, Verafin Holdings Inc., certain shareholders of Verafin (the “Sellers”), and Shareholder Representative Services LLC, solely in its capacity as the representative of the Sellers (incorporated herein by reference to Exhibit 2.3 to the Annual Report on Form 10-K for the year ended December 31, 2020 filed on February 23, 2021). | ||||||||
Agreement and Plan of Merger, dated as of June 10, 2023, by and among Nasdaq, Inc., Argus Merger Sub 1, Inc., Argus Merger Sub 2, LLC, Adenza Holdings, Inc. and Adenza Parent, LP. (incorporated herein by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on June 12, 2023).† | ||||||||
| Amended and Restated Certificate of Incorporation of Nasdaq (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on January 28, 2014). | ||||||||
| Certificate of Elimination of Nasdaq’s Series A Convertible Preferred Stock (incorporated herein by reference to Exhibit 3.1.1 to the Current Report on Form 8-K filed on January 28, 2014). | ||||||||
| Certificate of Amendment of Nasdaq’s Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on November 19, 2014). | ||||||||
| Certificate of Amendment of Nasdaq’s Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on September 8, 2015). | ||||||||
| Certificate of Amendment of Nasdaq’s Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on July 20, 2022). | ||||||||
| Nasdaq’s By-Laws (incorporated herein by reference to Exhibit 3.2 to the Current Report on Form 8-K filed on November 21, 2016). | ||||||||
| Form of Common Stock certificate (incorporated herein by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 filed on November 4, 2015). | ||||||||
| Stockholders’ Agreement, dated as of February 27, 2008, between Nasdaq, Inc. (f/k/a The NASDAQ OMX Group, Inc.) and Borse Dubai Limited (incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on March 3, 2008). | ||||||||
First Amendment to Stockholders’ Agreement, dated as of February 19, 2009, between Nasdaq, Inc. (f/k/a The NASDAQ OMX Group, Inc.) and Borse Dubai Limited (incorporated herein by reference to Exhibit 4.10.1 to the Annual Report on Form 10-K for the year ended December 31, 2008 filed on February 27, 2009). | ||||||||
Second Amendment to Nasdaq Stockholders’ Agreement, dated as of March 19, 2024, by and between Nasdaq, Inc. and Borse Dubai Limited (incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 20, 2024). | ||||||||
| Registration Rights Agreement, dated as of February 27, 2008, among Nasdaq, Inc. (f/k/a The NASDAQ OMX Group, Inc.), Borse Dubai Limited and Borse Dubai Nasdaq Share Trust (incorporated herein by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on March 3, 2008). | ||||||||
| First Amendment to Registration Rights Agreement, dated as of February 19, 2009, among Nasdaq, Inc. (f/k/a The NASDAQ OMX Group, Inc.), Borse Dubai Limited and Borse Dubai Nasdaq Share Trust (incorporated herein by reference to Exhibit 4.11.1 to the Annual Report on Form 10-K for the year ended December 31, 2008 filed on February 27, 2009). | ||||||||
| Stockholders’ Agreement, dated as of December 16, 2010, between Nasdaq, Inc. (f/k/a The NASDAQ OMX Group, Inc.) and Investor AB (incorporated herein by reference to Exhibit 4.12 to the Annual Report on Form 10-K for the year ended December 31, 2010 filed on February 24, 2011). | ||||||||
| First Amendment to Nasdaq Stockholders’ Agreement, dated as of December 14, 2022, between Nasdaq, Inc. and Investor AB (incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on December 16, 2022). | ||||||||
Stockholders’ Agreement, dated as of November 1, 2023, by and among Nasdaq, Inc., Adenza Parent, LP and Thoma Bravo, L.P. (incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on November 3, 2023). | ||||||||
| Registration Rights Agreement, dated as of November 1, 2023, by and among Nasdaq, Inc. and Adenza Parent, LP. (incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on November 3, 2023). | ||||||||
| Indenture, dated as of June 7, 2013, between Nasdaq, Inc. (f/k/a The NASDAQ OMX Group, Inc.) and Wells Fargo Bank, National Association, as Trustee (incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on June 10, 2013). | ||||||||
Fourth Supplemental Indenture, dated as of June 7, 2016, among Nasdaq, Inc. and Wells Fargo Bank, National Association, as Trustee (incorporated herein by reference to the Current Report on Form 8-K filed on June 7, 2016). | ||||||||
Sixth Supplemental Indenture, dated as of April 1, 2019, among Nasdaq, Inc., Wells Fargo Bank, National Association, as Trustee, and HSBC Bank USA, National Association, as paying agent and as registrar and transfer agent (incorporated herein by reference to Exhibit 4.2 to the Form 8-A filed on April 1, 2019). | ||||||||
Seventh Supplemental Indenture, dated February 13, 2020, among Nasdaq, Inc., Wells Fargo Bank, National Association, as Trustee, and HSBC Bank USA, National Association, as paying agent and as registrar and transfer agent (incorporated herein by reference to Exhibit 4.2 to the Company’s Form 8-A filed on February 13, 2020). | ||||||||
Eighth Supplemental Indenture, dated April 28, 2020, by and between Nasdaq, Inc. and Wells Fargo Bank, National Association, as Trustee (incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on April 28, 2020). | ||||||||
Tenth Supplemental Indenture, dated December 21, 2020, by and between Nasdaq, Inc. and Wells Fargo Bank, National Association, as Trustee (incorporated herein by reference to Exhibit 4.3 to the Current Report on Form 8-K filed on December 21, 2020). | ||||||||
Eleventh Supplemental Indenture, dated December 21, 2020, by and between Nasdaq, Inc. and Wells Fargo Bank, National Association, as Trustee (incorporated herein by reference to Exhibit 4.4 to the Current Report on Form 8-K filed on December 21, 2020). | ||||||||
Twelfth Supplemental Indenture, dated July 30, 2021, by and among Nasdaq, Inc., Wells Fargo Bank, National Association, as Trustee and HSBC Bank USA, National Association, as registrar and transfer agent (incorporated herein by reference to Exhibit 4.2 to the Company’s Form 8-A filed on July 30, 2021). | ||||||||
Thirteenth Supplemental Indenture, dated as of March 7, 2022, by and between Nasdaq, Inc. and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (incorporated herein by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on March 7, 2022). | ||||||||
Fourteenth Supplemental Indenture, dated as of June 28, 2023, by and between Nasdaq, Inc. and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on June 28, 2023). | ||||||||
Fifteenth Supplemental Indenture, dated as of June 28, 2023, by and between Nasdaq, Inc. and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (incorporated herein by reference to Exhibit 4.3 to the Current Report on Form 8-K filed on June 28, 2023). | ||||||||
Sixteenth Supplemental Indenture, dated as of June 28, 2023, by and between Nasdaq, Inc. and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (incorporated herein by reference to Exhibit 4.4 to the Current Report on Form 8-K filed on June 28, 2023). | ||||||||
Seventeenth Supplemental Indenture, dated as of June 28, 2023, by and between Nasdaq, Inc. and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (incorporated herein by reference to Exhibit 4.5 to the Current Report on Form 8-K filed on June 28, 2023). | ||||||||
Eighteenth Supplemental Indenture, dated as of June 28, 2023, by and between Nasdaq, Inc. and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (incorporated herein by reference to Exhibit 4.6 to the Current Report on Form 8-K filed on June 28, 2023). | ||||||||
Nineteenth Supplemental Indenture, dated as of June 28, 2023, by and between Nasdaq, Inc. and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee and HSBC Bank USA, National Association, as paying agent, registrar and transfer agent (incorporated herein by reference to Exhibit 4.7 to the Current Report on Form 8-K filed on June 28, 2023). | ||||||||
Description of Securities (incorporated herein by reference to Exhibit 4.21 to the Annual Report on Form 10-K for the year ended December 31, 2023 filed on February 21, 2024). | ||||||||
Amended and Restated Board Compensation Policy, effective on June 21, 2023 (incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 filed on August 2, 2023).* | ||||||||
| Nasdaq Executive Corporate Incentive Plan, effective as of January 1, 2015 (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on May 11, 2015).* | ||||||||
| Nasdaq, Inc. Equity Incentive Plan (as amended and restated as of April 24, 2018) (incorporated herein by reference to Exhibit 10.1 to the Form S-8 filed on May 25, 2018).* | ||||||||
| Form of Nasdaq Non-Qualified Stock Option Award Certificate (incorporated herein by reference to Exhibit 10.3 to the Annual Report on Form 10-K for the year ended December 31, 2010 filed on February 24, 2011).* | ||||||||
Form of Nasdaq Restricted Stock Unit Award Certificate (employees) (incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 filed on August 6, 2024).* | ||||||||
Form of Nasdaq Restricted Stock Unit Award Certificate (directors) (incorporated herein by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 filed on August 6, 2024).* | ||||||||
Form of Nasdaq Three-Year Performance Share Unit Agreement (incorporated herein by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 filed on August 6, 2024).* | ||||||||
Form of Nasdaq Two-Year Performance Share Unit Agreement (incorporated herein by reference to Exhibit 10.4 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 filed on August 6, 2024).* | ||||||||
| Form of Nasdaq Continuing Obligations Agreement (incorporated by reference to Exhibit 10.9 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed on February 23, 2022). | ||||||||
| Amended and Restated Supplemental Executive Retirement Plan, dated as of December 17, 2008 (incorporated herein by reference to Exhibit 10.6 to the Annual Report on Form 10-K for the year ended December 31, 2008 filed on February 27, 2009).* | ||||||||
| Amendment No. 1 to Amended and Restated Supplemental Executive Retirement Plan, effective as of December 31, 2008 (incorporated herein by reference to Exhibit 10.6.1 to the Annual Report on Form 10-K for the year ended December 31, 2008 filed on February 27, 2009).* | ||||||||
| Nasdaq Supplemental Employer Retirement Contribution Plan, dated as of December 17, 2008 (incorporated herein by reference to Exhibit 10.7 to the Annual Report on Form 10-K for the year ended December 31, 2008 filed on February 27, 2009).* | ||||||||
Nasdaq, Inc. Deferred Compensation Plan, effective July 1, 2022 (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 16, 2022).* | ||||||||
| Nonqualified Stock Option Award Certificate to Adena T. Friedman from Nasdaq, Inc. in connection with grant made on January 3, 2017 (incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 filed on November 7, 2017).* | ||||||||
Employment Agreement between Nasdaq and Adena Friedman, made and entered into on November 19, 2021 and effective as of January 1, 2022 (incorporated herein by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed on February 23, 2022).* | ||||||||
Nonqualified Stock Option Award Certificate to Adena T. Friedman from Nasdaq, Inc. in connection with grant made on January 3, 2022 (incorporated herein by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed on February 23, 2022).* | ||||||||
Employment Agreement by and between Nasdaq, Inc. and Bradley J. Peterson, dated June 22, 2022 (incorporated herein by reference to Exhibit 10.5 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 filed on August 3, 2022).* | ||||||||
Employment Offer Letter by and between Nasdaq, Inc. and Michelle Daly dated January 29, 2021 (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on May 3, 2021).* | ||||||||
General Release and Separation Agreement by and between Nasdaq, Inc. and Ann M. Dennison, dated as of August 31, 2023 (incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 filed on November 3, 2023).* | ||||||||
Employment Offer Letter by and between Nasdaq, Inc. and Sarah Youngwood, dated as of August 31, 2023 (incorporated herein by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 filed on November 3, 2023).* | ||||||||
Nasdaq Change in Control Severance Plan For Non-CEO Presidents, Executive Vice Presidents and Senior Vice Presidents, effective November 26, 2013, as amended December 6, 2022 (incorporated herein by reference to Exhibit 10.19 to the Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 22, 2023.* | ||||||||
Amended and Restated Credit Agreement, dated as of December 16, 2022, among Nasdaq, Inc., the various lenders and issuing bank party thereto and Bank of America, N.A., as administrative agent (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on December 16, 2022).† | ||||||||
Amendment No. 1 to Amended and Restated Credit Agreement, dated as of March 29, 2023, among Nasdaq, Inc., the Lenders party hereto, Bank of America, N.A., as administrative agent and BofA Securities, Inc., as Sustainability Coordinator (incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the quarter ended March 30, 2023 filed on May 4, 2023).† | ||||||||
Amendment No. 2 to Amended and Restated Credit Agreement, dated as of June 16, 2023, among Nasdaq, Inc., a Delaware corporation, the lenders party thereto and Bank of America, N.A., as administrative agent (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on June 20, 2023). | ||||||||
Amendment No. 3 to Amended and Restated Credit Agreement, dated as of August 2, 2024, among Nasdaq, Inc., a Delaware corporation, the lenders party thereto and Bank of America, N.A., as administrative agent (incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 filed on October 29, 2024).† | ||||||||
Amendment No. 4 to Amended and Restated Credit Agreement, dated as of December 16, 2024, among Nasdaq, Inc., a Delaware corporation, the lenders party thereto, Bank of America, N.A., as administrative agent and BofA Securities, Inc., as sustainability coordinator.† | ||||||||
Term Loan Credit Agreement, dated as of June 28, 2023, among Nasdaq, Inc., the lenders and other parties party thereto, and Bank of America, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on June 28, 2023).† | ||||||||
| Form of Commercial Paper Dealer Agreement between Nasdaq, Inc., as Issuer, and the Dealer party thereto (incorporated herein by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on April 26, 2017). | ||||||||
Verafin Holdings Inc. Amended and Restated Management Incentive Plan, effective as of October 3, 2022 (incorporated herein by reference to Exhibit 10.24 to the Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 22, 2023).* | ||||||||
Verafin Holdings Inc. Amended and Restated Management Incentive Plan Award Agreement, by and between Verafin Solutions ULC and Brendan Brothers, dated as of January 11, 2023 (incorporated by reference herein to Exhibit 10.25 to the Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 22, 2023).* | ||||||||
| Statement regarding computation of per share earnings (incorporated herein by reference from Note 13 to the consolidated financial statements under Part II, Item 8 of this Form 10-K). | ||||||||
Insider Trading Policy. | ||||||||
| List of all subsidiaries. | ||||||||
| Consent of Ernst & Young LLP. | ||||||||
| Powers of Attorney. | ||||||||
| Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”). | ||||||||
| Certification of Executive Vice President and Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley. | ||||||||
| Certifications Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley. | ||||||||
Supplemental Executive Officer Recoupment Policy (incorporated by reference herein to Exhibit 97.1 to the Annual Report on Form 10-K for the year ended December 31, 2023 filed on February 21, 2024).* | ||||||||
| 101 | The following materials from the Nasdaq, Inc. Annual Report on Form 10-K for the year ended December 31, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 2024 and December 31, 2023; (ii) Consolidated Statements of Income for the years ended December 31, 2024, 2023 and 2022 (iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2024, 2023 and 2022; (iv) Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2024, 2023 and 2022; (v) Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022; and (vi) notes to consolidated financial statements. | |||||||
| 104 | Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101. | |||||||
| Nasdaq, Inc. | ||||||||
| (Registrant) | ||||||||
| By: | /s/ Adena T. Friedman | |||||||
| Name: | Adena T. Friedman | |||||||
| Title: | Chief Executive Officer | |||||||
| Date: | February 21, 2025 | |||||||
| By: | /s/ Adena T. Friedman | ||||
| Name: | Adena T. Friedman | ||||
| Title: | Chief Executive Officer and Chair of the Board | ||||
| By: | /s/ Sarah Youngwood | ||||
| Name: | Sarah Youngwood | ||||
| Title: | Executive Vice President and Chief Financial Officer | ||||
| By: | /s/ Michelle Daly | ||||
| Name: | Michelle Daly | ||||
| Title: | Senior Vice President, Controller and Principal Accounting Officer | ||||
| By: | * | ||||
| Name: | Melissa M. Arnoldi | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Charlene T. Begley | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Essa Kazim | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Thomas A. Kloet | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Kathryn A. Koch | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Holden Spaht | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Michael R. Splinter | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Johan Torgeby | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Toni Townes-Whitley | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Jeffery W. Yabuki | ||||
| Title: | Director | ||||
| By: | * | ||||
| Name: | Alfred W. Zollar | ||||
| Title: | Director | ||||
| * Pursuant to Power of Attorney | |||||
| By: | /s/ John A. Zecca | ||||
| Name: | John A. Zecca | ||||
| Title: | Attorney-in-Fact | ||||
Calypso and AxiomSL on-premises license revenue recognition | |||||
| Description of the Matter | As described in Note 2 to the consolidated financial statements, the Company recognizes revenue within its Regulatory Technology and Capital Markets Technology products for AxiomSL and Calypso on-premises license agreements, respectively. The AxiomSL on-premises software offering includes both license and post-contract customer support, which includes frequent and ongoing mandatory regulatory updates. Both the AxiomSL on-premises license and the post-contract customer support, inclusive of the frequent and ongoing mandatory regulatory updates are accounted for as a single performance obligation and recognized ratably over the contract term. For the on-premises Calypso capital markets product, distinct performance obligations are recognized for the license and post-contract customer support and the performance obligation of the on-premises license revenue is recognized upfront at the point in time when the software is made available to the user. Auditing the Company’s initial identification of performance obligations along with the timing over which those performance obligations are satisfied for the acquired AxiomSL and Calypso on-premise license agreements required complex judgment. | ||||
| How We Addressed the Matter in Our Audit | We obtained an understanding, performed a walkthrough of the process and evaluated the design and tested the operating effectiveness of controls over the Company's processes for identifying performance obligations and determining the timing over which the performance obligations are satisfied with respect to these products. To test the Company’s judgments and conclusions related to the identification of performance obligations and timing of satisfaction of those performance obligations, our audit procedures included, among others, obtaining an understanding of the Company’s AxiomSL and Calypso service offerings and evaluating management’s conclusions regarding which were distinct. We involved subject matter resources to assist in testing management’s identification of performance obligations and determining timing over which they are satisfied. We read a sample of executed contracts to assess management’s evaluation of significant terms, including the determination of distinct performance obligations. | ||||
| December 31, 2024 | December 31, 2023 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
| Restricted cash and cash equivalents | |||||||||||
Default funds and margin deposits (including restricted cash and cash equivalents of $ | |||||||||||
| Financial investments | |||||||||||
| Receivables, net | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Property and equipment, net | |||||||||||
| Goodwill | |||||||||||
| Intangible assets, net | |||||||||||
| Operating lease assets | |||||||||||
| Other non-current assets | |||||||||||
| Total assets | $ | $ | |||||||||
| Liabilities | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable and accrued expenses | $ | $ | |||||||||
| Section 31 fees payable to SEC | |||||||||||
| Accrued personnel costs | |||||||||||
| Deferred revenue | |||||||||||
| Other current liabilities | |||||||||||
| Default funds and margin deposits | |||||||||||
| Short-term debt | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt | |||||||||||
| Deferred tax liabilities, net | |||||||||||
| Operating lease liabilities | |||||||||||
| Other non-current liabilities | |||||||||||
| Total liabilities | |||||||||||
| Commitments and contingencies | |||||||||||
| Equity | |||||||||||
| Nasdaq stockholders’ equity: | |||||||||||
Common stock, $ | |||||||||||
| Additional paid-in capital | |||||||||||
Common stock in treasury, at cost: | ( | ( | |||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Retained earnings | |||||||||||
| Total Nasdaq stockholders’ equity | |||||||||||
| Noncontrolling interests | |||||||||||
| Total equity | |||||||||||
| Total liabilities and equity | $ | $ | |||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Revenues: | |||||||||||||||||
| Capital Access Platforms | $ | $ | $ | ||||||||||||||
| Financial Technology | |||||||||||||||||
| Market Services | |||||||||||||||||
| Other revenues | |||||||||||||||||
| Total revenues | |||||||||||||||||
| Transaction-based expenses: | |||||||||||||||||
| Transaction rebates | ( | ( | ( | ||||||||||||||
| Brokerage, clearance and exchange fees | ( | ( | ( | ||||||||||||||
| Revenues less transaction-based expenses | |||||||||||||||||
| Operating expenses: | |||||||||||||||||
| Compensation and benefits | |||||||||||||||||
| Professional and contract services | |||||||||||||||||
| Technology and communication infrastructure | |||||||||||||||||
| Occupancy | |||||||||||||||||
| General, administrative and other | |||||||||||||||||
| Marketing and advertising | |||||||||||||||||
| Depreciation and amortization | |||||||||||||||||
| Regulatory | |||||||||||||||||
| Merger and strategic initiatives | |||||||||||||||||
| Restructuring charges | |||||||||||||||||
| Total operating expenses | |||||||||||||||||
| Operating income | |||||||||||||||||
| Interest income | |||||||||||||||||
| Interest expense | ( | ( | ( | ||||||||||||||
Other income (loss) | ( | ||||||||||||||||
| Net income (loss) from unconsolidated investees | ( | ||||||||||||||||
| Income before income taxes | |||||||||||||||||
| Income tax provision | |||||||||||||||||
| Net income | |||||||||||||||||
| Net loss attributable to noncontrolling interests | |||||||||||||||||
| Net income attributable to Nasdaq | $ | $ | $ | ||||||||||||||
| Per share information: | |||||||||||||||||
| Basic earnings per share | $ | $ | $ | ||||||||||||||
| Diluted earnings per share | $ | $ | $ | ||||||||||||||
| Cash dividends declared per common share | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Net income | $ | $ | $ | ||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||
Foreign currency translation gains (losses) | ( | ( | |||||||||||||||
Income tax benefit (expense)(1) | ( | ( | |||||||||||||||
| Foreign currency translation, net | ( | ( | |||||||||||||||
| Employee benefit plan adjustment | |||||||||||||||||
Income tax expense | ( | ( | ( | ||||||||||||||
| Employee benefit plan, net | |||||||||||||||||
Unrealized gain (loss) on derivatives instruments, net | ( | ||||||||||||||||
| Total other comprehensive income (loss), net of tax | ( | ( | |||||||||||||||
| Comprehensive income | |||||||||||||||||
| Comprehensive loss attributable to noncontrolling interests | |||||||||||||||||
| Comprehensive income attributable to Nasdaq | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||||||||||||||||||||
| Shares | $ | Shares | $ | Shares | $ | ||||||||||||||||||||||||||||||
| Common stock | |||||||||||||||||||||||||||||||||||
| Beginning balance | |||||||||||||||||||||||||||||||||||
| Acquisition-related stock issuance | |||||||||||||||||||||||||||||||||||
| Ending balance | |||||||||||||||||||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||||||||||||||||||
| Beginning balance | |||||||||||||||||||||||||||||||||||
| Share repurchase program | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
ASR agreement | ( | ( | |||||||||||||||||||||||||||||||||
| Share-based compensation | |||||||||||||||||||||||||||||||||||
| Acquisition-related stock issuance | |||||||||||||||||||||||||||||||||||
| Other issuances of common stock, net | |||||||||||||||||||||||||||||||||||
| Ending balance | |||||||||||||||||||||||||||||||||||
| Common stock in treasury, at cost | |||||||||||||||||||||||||||||||||||
| Beginning balance | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other employee stock activity | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
| Ending balance | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||||||||||||||||||
| Beginning balance | ( | ( | ( | ||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | ( | ( | |||||||||||||||||||||||||||||||||
| Ending balance | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Retained earnings | |||||||||||||||||||||||||||||||||||
| Beginning balance | |||||||||||||||||||||||||||||||||||
| Net income attributable to Nasdaq | |||||||||||||||||||||||||||||||||||
| Cash dividends declared and paid | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Ending balance | |||||||||||||||||||||||||||||||||||
| Total Nasdaq stockholders’ equity | |||||||||||||||||||||||||||||||||||
| Noncontrolling interests | |||||||||||||||||||||||||||||||||||
| Beginning balance | |||||||||||||||||||||||||||||||||||
Net activity related to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||
| Ending balance | |||||||||||||||||||||||||||||||||||
| Total Equity | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| Cash flows from operating activities: | 2024 | 2023 | 2022 | ||||||||||||||
| Net income | $ | $ | $ | ||||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
| Depreciation and amortization | |||||||||||||||||
| Share-based compensation | |||||||||||||||||
| Deferred income taxes | ( | ||||||||||||||||
| Extinguishment of debt and bridge fees | |||||||||||||||||
| Non-cash restructuring charges | |||||||||||||||||
| Net (income) loss from unconsolidated investees | ( | ( | |||||||||||||||
| Operating lease asset impairments | |||||||||||||||||
| Adenza purchase accounting adjustment | |||||||||||||||||
| Other reconciling items included in net income | |||||||||||||||||
| Net change in operating assets and liabilities: | |||||||||||||||||
| Receivables, net | ( | ( | |||||||||||||||
| Other assets | ( | ||||||||||||||||
| Accounts payable and accrued expenses | ( | ||||||||||||||||
| Section 31 fees payable to SEC | ( | ||||||||||||||||
| Accrued personnel costs | |||||||||||||||||
| Deferred revenue | |||||||||||||||||
| Other liabilities | ( | ( | |||||||||||||||
| Net cash provided by operating activities | |||||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||
| Purchases of securities | ( | ( | ( | ||||||||||||||
| Proceeds from sales and redemptions of securities | |||||||||||||||||
| Acquisition of businesses, net of cash and cash equivalents acquired | ( | ( | |||||||||||||||
| Purchases of property and equipment | ( | ( | ( | ||||||||||||||
Investments related to default funds and margin deposits, net(1) | ( | ( | |||||||||||||||
| Other investing activities | ( | ( | |||||||||||||||
| Net cash provided by (used in) investing activities | ( | ( | |||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||
Proceeds from (repayments of) commercial paper, net | ( | ( | |||||||||||||||
| Repayments of debt and credit commitment | ( | ( | ( | ||||||||||||||
| Proceeds from issuances of debt, net of issuance costs | |||||||||||||||||
| Repurchases of common stock | ( | ( | ( | ||||||||||||||
| ASR agreement | ( | ||||||||||||||||
| Dividends paid | ( | ( | ( | ||||||||||||||
| Payments related to employee shares withheld for taxes | ( | ( | ( | ||||||||||||||
| Default funds and margin deposits | ( | ||||||||||||||||
| Other financing activities | |||||||||||||||||
| Net cash provided by (used in) financing activities | ( | ||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | ( | ( | |||||||||||||||
| Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | ( | ||||||||||||||||
Cash and cash equivalents, restricted cash and cash equivalents at beginning of period | |||||||||||||||||
| Cash and cash equivalents, restricted cash and cash equivalents at end of period | $ | $ | $ | ||||||||||||||
| Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents | |||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | ||||||||||||||
| Restricted cash and cash equivalents | |||||||||||||||||
| Restricted cash and cash equivalents (default funds and margin deposits) | |||||||||||||||||
| Total | $ | $ | $ | ||||||||||||||
| Supplemental Disclosure Cash Flow Information | |||||||||||||||||
| Interest paid | $ | $ | $ | ||||||||||||||
| Income taxes paid, net of refund | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Capital Access Platforms | |||||||||||||||||
| Data & Listing Services | $ | $ | $ | ||||||||||||||
| Index | |||||||||||||||||
| Workflow & Insights | |||||||||||||||||
| Financial Technology | |||||||||||||||||
| Financial Crime Management Technology | |||||||||||||||||
| Regulatory Technology | |||||||||||||||||
| Capital Markets Technology | |||||||||||||||||
| Market Services, net | |||||||||||||||||
| Other revenues | |||||||||||||||||
| Revenues less transaction-based expenses | $ | $ | $ | ||||||||||||||
| Financial Crime Management Technology | Regulatory Technology | Capital Markets Technology | Workflow & Insights | Total | |||||||||||||||||||||||||
| (in millions) | |||||||||||||||||||||||||||||
| 2025 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| 2026 | |||||||||||||||||||||||||||||
| 2027 | |||||||||||||||||||||||||||||
| 2028 | |||||||||||||||||||||||||||||
| 2029 | |||||||||||||||||||||||||||||
| 2030+ | |||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| (in millions, except price per share) | |||||
| Shares of Nasdaq common stock issued | |||||
| Closing price per share of Nasdaq common stock on November 1, 2023 | $ | ||||
| Fair value of equity portion of the purchase consideration | $ | ||||
| Cash consideration | $ | ||||
| Total purchase consideration | $ | ||||
| (in millions) | |||||
| Goodwill | $ | ||||
| Acquired intangible assets | |||||
| Receivables, net | |||||
| Other net assets acquired | |||||
| Cash and cash equivalents | |||||
| Accrued personnel costs | ( | ||||
| Deferred revenue | ( | ||||
| Deferred tax liability on acquired intangible assets | ( | ||||
| Total purchase consideration | $ | ||||
Customer Relationships | Technology | Trade Names | Total Acquired Intangible Assets | |||||||||||
| Intangible asset value (in millions) | $ | $ | $ | $ | ||||||||||
| Discount rate used | % | % | % | |||||||||||
| Estimated average useful life | ||||||||||||||
| Year Ended December 31, | |||||||||||
| 2023 | 2022 | ||||||||||
| (in millions) | |||||||||||
Pro forma revenues less transaction-based expenses | $ | $ | |||||||||
Pro forma operating income | |||||||||||
Pro forma net income attributable to Nasdaq | |||||||||||
| (in millions) | |||||
| Capital Access Platforms | |||||
| Balance at December 31, 2023 | $ | ||||
| Foreign currency translation adjustments | ( | ||||
| Balance at December 31, 2024 | $ | ||||
| Financial Technology | |||||
| Balance at December 31, 2023 | $ | ||||
Measurement period adjustment | |||||
| Foreign currency translation adjustments | ( | ||||
| Balance at December 31, 2024 | $ | ||||
| Market Services | |||||
| Balance at December 31, 2023 | $ | ||||
| Foreign currency translation adjustments | ( | ||||
| Balance at December 31, 2024 | $ | ||||
| Total | |||||
| Balance at December 31, 2023 | $ | ||||
| Measurement period adjustments | |||||
| Foreign currency translation adjustments | ( | ||||
| Balance at December 31, 2024 | $ | ||||
| December 31, 2024 | December 31, 2023 | ||||||||||
| Finite-Lived Intangible Assets | (in millions) | ||||||||||
| Gross Amount | |||||||||||
| Technology | $ | $ | |||||||||
| Customer relationships | |||||||||||
| Trade names and other | |||||||||||
| Foreign currency translation adjustment | ( | ( | |||||||||
| Total gross amount | $ | $ | |||||||||
| Accumulated Amortization | |||||||||||
| Technology | $ | ( | $ | ( | |||||||
| Customer relationships | ( | ( | |||||||||
| Trade names and other | ( | ( | |||||||||
| Foreign currency translation adjustment | |||||||||||
| Total accumulated amortization | $ | ( | $ | ( | |||||||
| Net Amount | |||||||||||
| Technology | $ | $ | |||||||||
| Customer relationships | |||||||||||
| Trade names and other | |||||||||||
| Foreign currency translation adjustment | ( | ( | |||||||||
| Total finite-lived intangible assets | $ | $ | |||||||||
| Indefinite-Lived Intangible Assets | |||||||||||
| Exchange and clearing registrations | $ | $ | |||||||||
| Trade names | |||||||||||
| Licenses | |||||||||||
| Foreign currency translation adjustment | ( | ( | |||||||||
| Total indefinite-lived intangible assets | $ | $ | |||||||||
| Total intangible assets, net | $ | $ | |||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Amortization expense | $ | $ | $ | ||||||||||||||
| (in millions) | |||||
| 2025 | $ | ||||
| 2026 | |||||
| 2027 | |||||
| 2028 | |||||
| 2029 | |||||
| 2030+ | |||||
| Total | $ | ||||
| December 31, 2024 | December 31, 2023 | ||||||||||
| (in millions) | |||||||||||
| Financial investments | $ | $ | |||||||||
| Equity method investments | |||||||||||
| Equity securities | |||||||||||
| December 31, 2024 | December 31, 2023 | ||||||||||
| (in millions) | |||||||||||
| Data processing equipment and software | $ | $ | |||||||||
| Furniture, equipment and leasehold improvements | |||||||||||
| Total property and equipment | |||||||||||
| Less: accumulated depreciation and amortization and impairment charges | ( | ( | |||||||||
| Total property and equipment, net | $ | $ | |||||||||
| Balance at December 31, 2023 | Additions | Revenue Recognized | Adjustments | Balance at December 31, 2024 | |||||||||||||
| (in millions) | |||||||||||||||||
| Capital Access Platforms: | |||||||||||||||||
| Initial Listings | $ | $ | $ | ( | $ | ( | $ | ||||||||||
| Annual Listings | ( | ( | |||||||||||||||
| Workflow & Insights | ( | ||||||||||||||||
| Financial Technology: | |||||||||||||||||
| Financial Crime Management Technology | ( | ( | |||||||||||||||
| Regulatory Technology | ( | ||||||||||||||||
| Capital Markets Technology | ( | ( | |||||||||||||||
| Other | ( | ( | |||||||||||||||
| Total | $ | $ | $ | ( | $ | $ | |||||||||||
Fiscal year ended: | 2025 | 2026 | 2027 | 2028 | 2029 | 2030+ | Total | ||||||||||||||||
| (in millions) | |||||||||||||||||||||||
| Capital Access Platforms: | |||||||||||||||||||||||
| Initial Listings | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||
| Annual Listings | |||||||||||||||||||||||
| Workflow & Insights | |||||||||||||||||||||||
| Financial Technology: | |||||||||||||||||||||||
| Financial Crime Management Technology | |||||||||||||||||||||||
| Regulatory Technology | |||||||||||||||||||||||
| Capital Markets Technology | |||||||||||||||||||||||
| Other | |||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||
| December 31, 2023 | Additions | Payments, Foreign Currency Translation and Accretion | December 31, 2024 | ||||||||||||||||||||
| Short-term debt: | |||||||||||||||||||||||
| Commercial paper | $ | $ | $ | ( | $ | ||||||||||||||||||
2025 Notes | ( | ||||||||||||||||||||||
| Total short-term debt | $ | $ | $ | ( | $ | ||||||||||||||||||
| Long-term debt - senior unsecured notes: | |||||||||||||||||||||||
2026 Notes | |||||||||||||||||||||||
2028 Notes | ( | ||||||||||||||||||||||
2029 Notes | ( | ||||||||||||||||||||||
2030 Notes | ( | ||||||||||||||||||||||
2031 Notes | |||||||||||||||||||||||
2032 Notes | ( | ||||||||||||||||||||||
2033 Notes | ( | ||||||||||||||||||||||
2034 Notes | ( | ||||||||||||||||||||||
2040 Notes | |||||||||||||||||||||||
2050 Notes | |||||||||||||||||||||||
2052 Notes | |||||||||||||||||||||||
2053 Notes | |||||||||||||||||||||||
2063 Notes | |||||||||||||||||||||||
2023 Term Loan | ( | ||||||||||||||||||||||
| 2022 Revolving Credit Facility | ( | ( | |||||||||||||||||||||
| Total long-term debt | $ | $ | $ | ( | $ | ||||||||||||||||||
| Total debt obligations | $ | $ | $ | ( | $ | ||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
Savings Plan expense | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
Retirement Plans expense | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Share-based compensation expense before income taxes | $ | $ | $ | ||||||||||||||
| Restricted Stock | |||||||||||
| Number of Awards | Weighted-Average Grant Date Fair Value | ||||||||||
| Unvested at December 31, 2021 | $ | ||||||||||
| Granted | |||||||||||
| Vested | ( | ||||||||||
| Forfeited | ( | ||||||||||
| Unvested at December 31, 2022 | |||||||||||
| Granted | |||||||||||
| Vested | ( | ||||||||||
| Forfeited | ( | ||||||||||
| Unvested at December 31, 2023 | |||||||||||
| Granted | |||||||||||
| Vested | ( | ||||||||||
| Forfeited | ( | ||||||||||
Unvested at December 31, 2024 | $ | ||||||||||
2024 Grants | 2023 Grant | ||||||||||
| Weighted-average risk-free interest rate | % | % | |||||||||
Expected volatility | % | % | |||||||||
| Weighted-average grant date share price | $ | $ | |||||||||
| Weighted-average fair value at grant date | $ | $ | |||||||||
PSUs | ||||||||||||||
| Three-Year Program | ||||||||||||||
| Number of Awards | Weighted-Average Grant Date Fair Value | |||||||||||||
| Unvested at December 31, 2021 | $ | |||||||||||||
| Granted | ||||||||||||||
| Vested | ( | |||||||||||||
| Forfeited | ( | |||||||||||||
| Unvested at December 31, 2022 | $ | |||||||||||||
| Granted | ||||||||||||||
| Vested | ( | |||||||||||||
| Forfeited | ( | |||||||||||||
| Unvested at December 31, 2023 | $ | |||||||||||||
| Granted | ||||||||||||||
| Vested | ( | |||||||||||||
| Forfeited | ( | |||||||||||||
Unvested at December 31, 2024 | $ | |||||||||||||
Number of Stock Options | Weighted-Average Exercise Price | Weighted- Average Remaining Contractual Term (in years) | Aggregate Intrinsic Value (in millions) | |||||||||||
| Outstanding at December 31, 2021 | $ | |||||||||||||
| Granted | $ | |||||||||||||
| Outstanding at December 31, 2022 | $ | |||||||||||||
| Outstanding at December 31, 2023 | $ | |||||||||||||
Outstanding at December 31, 2024 | $ | $ | ||||||||||||
Exercisable at December 31, 2024 | $ | $ | ||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
Number of shares purchased by employees | |||||||||||||||||
Weighted-average price of shares purchased | $ | $ | $ | ||||||||||||||
Compensation expense (in millions) | $ | $ | $ | ||||||||||||||
| Year Ended December 31, 2024 | |||||
| Number of shares of common stock repurchased | |||||
| Average price paid per share | $ | ||||
Total purchase price (in millions) | $ | ||||
| Declaration Date | Dividend Per Common Share | Record Date | Total Amount Paid | Payment Date | ||||||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||||
| January 29, 2024 | $ | March 14, 2024 | $ | March 28, 2024 | ||||||||||||||||||||||
| April 24, 2024 | June 14, 2024 | June 28, 2024 | ||||||||||||||||||||||||
| July 24, 2024 | September 13, 2024 | September 27, 2024 | ||||||||||||||||||||||||
| October 22, 2024 | December 6, 2024 | December 20, 2024 | ||||||||||||||||||||||||
| $ | ||||||||||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Numerator: | (in millions, except share and per share amounts) | ||||||||||||||||
| Net income attributable to common shareholders | $ | $ | $ | ||||||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average common shares outstanding for basic earnings per share | |||||||||||||||||
| Weighted-average effect of dilutive securities - Employee equity awards | |||||||||||||||||
| Weighted-average common shares outstanding for diluted earnings per share | |||||||||||||||||
| Basic and diluted earnings per share: | |||||||||||||||||
| Basic earnings per share | $ | $ | $ | ||||||||||||||
| Diluted earnings per share | $ | $ | $ | ||||||||||||||
| December 31, 2024 | |||||||||||||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
European government debt securities | $ | $ | $ | $ | |||||||||||||||||||
Swedish mortgage bonds | |||||||||||||||||||||||
| Time deposits | |||||||||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | |||||||||||||||||||
| December 31, 2023 | |||||||||||||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
European government debt securities | $ | $ | $ | $ | |||||||||||||||||||
State-owned enterprises and municipal securities | |||||||||||||||||||||||
Swedish mortgage bonds | |||||||||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | |||||||||||||||||||
| December 31, 2024 | |||||||||||||||||
| Cash Contributions | Non-Cash Contributions | Total Contributions | |||||||||||||||
| (in millions) | |||||||||||||||||
| Default fund contributions | $ | $ | $ | ||||||||||||||
| Margin deposits | |||||||||||||||||
| Total | $ | $ | $ | ||||||||||||||
| December 31, 2024 | December 31, 2023 | ||||||||||
| (in millions) | |||||||||||
| Demand deposits | $ | $ | |||||||||
| Central bank certificates | |||||||||||
| Restricted cash and cash equivalents | $ | $ | |||||||||
| European government debt securities | |||||||||||
| Reverse repurchase agreements | |||||||||||
| Multilateral development bank debt securities | |||||||||||
| Investments | $ | $ | |||||||||
| Total | $ | $ | |||||||||
| December 31, 2024 | |||||
| (in millions) | |||||
| Commodity and seafood options, futures and forwards | $ | ||||
| Fixed-income options and futures | |||||
| Stock options and futures | |||||
| Index options and futures | |||||
| Total | $ | ||||
| Year Ended December 31, | |||||||||||
| 2024 | 2023 | ||||||||||
| Commodity and seafood options, futures and forwards | |||||||||||
| Fixed-income options and futures | |||||||||||
| Stock options and futures | |||||||||||
| Index options and futures | |||||||||||
| Total | |||||||||||
| Leases | Balance Sheet Classification | December 31, 2024 | December 31, 2023 | |||||||||||||||||
| Assets: | (in millions) | |||||||||||||||||||
| Operating lease assets | Operating lease assets | $ | $ | |||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Current lease liabilities | $ | $ | ||||||||||||||||||
| Non-current lease liabilities | Operating lease liabilities | |||||||||||||||||||
| Total lease liabilities | $ | $ | ||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Operating lease cost | $ | $ | $ | ||||||||||||||
| Variable lease cost | |||||||||||||||||
| Sublease income | ( | ( | ( | ||||||||||||||
| Total lease cost | $ | $ | $ | ||||||||||||||
| December 31, 2024 | ||||||||
| (in millions) | ||||||||
| 2025 | $ | |||||||
| 2026 | ||||||||
| 2027 | ||||||||
| 2028 | ||||||||
2029 | ||||||||
2030+ | ||||||||
| Total lease payments | $ | |||||||
| Less: interest | ( | |||||||
| Present value of lease liabilities | $ | |||||||
| December 31, 2024 | ||||||||
| Weighted-average remaining lease term (in years) | ||||||||
| Weighted-average discount rate | % | |||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Cash paid for amounts included in the measurement of operating lease liabilities | $ | $ | $ | ||||||||||||||
| Lease assets obtained in exchange for operating lease liabilities | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Domestic | $ | $ | $ | ||||||||||||||
| Foreign | |||||||||||||||||
| Income before income tax provision | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
Current income taxes provision: | |||||||||||||||||
| Federal | $ | $ | $ | ||||||||||||||
| State | |||||||||||||||||
| Foreign | |||||||||||||||||
| Total current income taxes provision | |||||||||||||||||
| Deferred income taxes provision (benefit): | |||||||||||||||||
| Federal | ( | ||||||||||||||||
| State | |||||||||||||||||
| Foreign | ( | ( | |||||||||||||||
Total deferred income taxes (benefit) provision | ( | ||||||||||||||||
| Total income tax provision | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
| Federal income tax provision at the statutory rate | % | % | % | ||||||||||||||
| State income tax provision, net of federal effect | % | % | % | ||||||||||||||
| Excess tax benefits related to employee share-based compensation | ( | % | ( | % | ( | % | |||||||||||
| Non-U.S. subsidiary earnings | % | % | % | ||||||||||||||
| Tax credits and deductions | ( | % | ( | % | ( | % | |||||||||||
| Change in unrecognized tax benefits | % | % | % | ||||||||||||||
| Deduction for foreign derived intangible income | ( | % | ( | % | ( | % | |||||||||||
Intra-group transfer of IP | % | % | % | ||||||||||||||
| Other, net | % | ( | % | ( | % | ||||||||||||
| Actual income tax provision | % | % | % | ||||||||||||||
| December 31, | |||||||||||
2024 | 2023 | ||||||||||
| (in millions) | |||||||||||
| Deferred tax assets: | |||||||||||
| Deferred revenues | $ | $ | |||||||||
| Foreign net operating loss | |||||||||||
| Capitalized research and development costs | |||||||||||
| State net operating loss | |||||||||||
| Compensation and benefits | |||||||||||
Deferred interest expense | |||||||||||
| Tax credits | |||||||||||
| Federal benefit of uncertain tax positions | |||||||||||
| Operating lease liabilities | |||||||||||
| Other | |||||||||||
| Gross deferred tax assets | |||||||||||
| Less: valuation allowance | ( | ||||||||||
| Total deferred tax assets, net of valuation allowance | $ | $ | |||||||||
| Deferred tax liabilities: | |||||||||||
Depreciation | $ | ( | $ | ( | |||||||
| Amortization of acquired intangible assets and goodwill | ( | ( | |||||||||
| Investments | ( | ( | |||||||||
| Unrealized gains | ( | ( | |||||||||
| Operating lease assets | ( | ( | |||||||||
| Other | ( | ( | |||||||||
| Gross deferred tax liabilities | $ | ( | $ | ( | |||||||
Net deferred tax liabilities | $ | ( | $ | ( | |||||||
Reported as: | |||||||||||
| Non-current deferred tax assets | $ | $ | |||||||||
Deferred tax liabilities, net | ( | ( | |||||||||
Net deferred tax liabilities | $ | ( | $ | ( | |||||||
| Jurisdiction | December 31, 2024 | Expiration Date | ||||||
| (in millions) | ||||||||
| Foreign NOL | $ | 2039-2044 | ||||||
U.S. state and local NOL | 2025-2043 | |||||||
| Year Ended December 31, | |||||||||||||||||
2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Beginning balance | $ | $ | $ | ||||||||||||||
| Additions as a result of tax positions taken in prior periods | |||||||||||||||||
| Additions as a result of tax positions taken in the current period | |||||||||||||||||
| Reductions related to settlements with taxing authorities | ( | ( | ( | ||||||||||||||
| Reductions as a result of lapses of the applicable statute of limitations | ( | ( | ( | ||||||||||||||
| Ending balance | $ | $ | $ | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Capital Access Platforms | |||||||||||||||||
| Total revenues | $ | $ | $ | ||||||||||||||
Direct and directly consumed expenses | |||||||||||||||||
Other expenses | |||||||||||||||||
| Operating income | $ | $ | $ | ||||||||||||||
Depreciation and amortization | |||||||||||||||||
| Purchase of property and equipment | |||||||||||||||||
| Financial Technology | |||||||||||||||||
| Total revenues | $ | $ | $ | ||||||||||||||
| Direct and directly consumed expenses | |||||||||||||||||
Other expenses | |||||||||||||||||
| Operating income | $ | $ | $ | ||||||||||||||
Depreciation and amortization | |||||||||||||||||
| Purchase of property and equipment | |||||||||||||||||
| Market Services | |||||||||||||||||
| Total revenues | $ | $ | $ | ||||||||||||||
Transaction-based expenses | ( | ( | ( | ||||||||||||||
| Revenues less transaction-based expenses | $ | $ | $ | ||||||||||||||
| Direct and directly consumed expenses | |||||||||||||||||
Other expenses | |||||||||||||||||
| Operating income | $ | $ | $ | ||||||||||||||
Depreciation and amortization | |||||||||||||||||
Purchase of property and equipment | |||||||||||||||||
| Corporate | |||||||||||||||||
| Total revenues | $ | $ | $ | ||||||||||||||
Other expenses | |||||||||||||||||
| Operating loss | $ | ( | $ | ( | $ | ( | |||||||||||
| Depreciation and amortization | |||||||||||||||||
| Consolidated | |||||||||||||||||
| Total revenues | $ | $ | $ | ||||||||||||||
| Transaction-based expenses | ( | ( | ( | ||||||||||||||
| Revenues less transaction-based expenses | $ | $ | $ | ||||||||||||||
| Direct and directly consumed expenses | |||||||||||||||||
Other expenses | |||||||||||||||||
| Operating income | $ | $ | $ | ||||||||||||||
| Depreciation and amortization | |||||||||||||||||
| Purchase of property and equipment | |||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Revenues: | |||||||||||||||||
Divested businesses | $ | $ | $ | ||||||||||||||
Adenza purchase accounting adjustment | ( | ||||||||||||||||
| Expenses: | |||||||||||||||||
| Amortization expense of acquired intangible assets | |||||||||||||||||
| Merger and strategic initiatives expense | |||||||||||||||||
| Restructuring charges | |||||||||||||||||
| Lease asset impairments | |||||||||||||||||
| Legal and regulatory matters | |||||||||||||||||
| Extinguishment of debt | |||||||||||||||||
| Pension Settlement | |||||||||||||||||
| Expenses - divested businesses | |||||||||||||||||
| Other | |||||||||||||||||
| Total expenses | $ | $ | $ | ||||||||||||||
| Operating loss | $ | ( | $ | ( | $ | ( | |||||||||||
| Total Revenues | Property and Equipment, Net | ||||||||||
2024: | (in millions) | ||||||||||
| United States | $ | $ | |||||||||
All other countries | |||||||||||
| Total | $ | $ | |||||||||
2023: | |||||||||||
| United States | $ | $ | |||||||||
All other countries | |||||||||||
| Total | $ | $ | |||||||||
| 2022: | |||||||||||
| United States | $ | $ | |||||||||
All other countries | |||||||||||
| Total | $ | $ | |||||||||
Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Asset impairment charges | |||||||||||||||||
| Adenza restructuring | $ | $ | $ | ||||||||||||||
| Divisional realignment | |||||||||||||||||
| Consulting services | |||||||||||||||||
| Adenza restructuring | |||||||||||||||||
| Divisional realignment | |||||||||||||||||
| Employee-related costs | |||||||||||||||||
| Adenza restructuring | |||||||||||||||||
| Divisional realignment | |||||||||||||||||
| Other | |||||||||||||||||
| Adenza restructuring | |||||||||||||||||
| Divisional realignment | |||||||||||||||||
| Total restructuring charges | $ | $ | $ | ||||||||||||||
| Total Program Costs Incurred | |||||||||||||||||
| Adenza restructuring | $ | ||||||||||||||||
| Divisional realignment | $ | ||||||||||||||||